Adtalem Global Education (NYSE:CVSA) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen cut shares of Adtalem Global Education (NYSE:CVSA) from a buy rating to a hold rating in a research note issued to investors on Saturday morning.

CVSA has been the subject of several other reports. Weiss Ratings assumed coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Truist Financial assumed coverage on Adtalem Global Education in a research report on Tuesday, March 24th. They issued a “buy” rating and a $130.00 target price for the company. Barrington Research reiterated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a research report on Friday, April 17th. Finally, Zacks Research downgraded Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $150.00.

Adtalem Global Education Trading Up 13.4%

Adtalem Global Education stock opened at $132.68 on Friday. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $4.58 billion, a P/E ratio of 20.67, a PEG ratio of 1.13 and a beta of 0.63. Adtalem Global Education has a 12 month low of $86.97 and a 12 month high of $156.26. The company has a 50-day moving average price of $110.78.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, beating the consensus estimate of $1.73 by $0.25. The firm had revenue of $487.03 million during the quarter. Adtalem Global Education had a return on equity of 19.98% and a net margin of 12.26%.Adtalem Global Education’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, analysts predict that Adtalem Global Education will post 8.05 earnings per share for the current fiscal year.

Insider Buying and Selling at Adtalem Global Education

In related news, Director Michael W. Malafronte purchased 8,890 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was bought at an average price of $100.94 per share, with a total value of $897,356.60. Following the completion of the purchase, the director owned 25,395 shares in the company, valued at approximately $2,563,371.30. This represents a 53.86% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Insiders bought a total of 37,236 shares of company stock valued at $3,752,866 over the last ninety days. Corporate insiders own 2.50% of the company’s stock.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.